Go Pro

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 11.90 +0.35 (+3.03%)
As of 11:41 AM Eastern

BVC vs. EKF, SPEC, CREO, IUG, and NCYT

Should you buy BATM Advanced Communications stock or one of its competitors? BATM Advanced Communications's main competitors and comparable companies include EKF Diagnostics (EKF), INSPECS Group (SPEC), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), and Novacyt (NCYT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does BATM Advanced Communications compare to EKF Diagnostics?

EKF Diagnostics (LON:EKF) and BATM Advanced Communications (LON:BVC) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

EKF Diagnostics has higher earnings, but lower revenue than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EKF Diagnostics£51.56M2.16£4.68M£0.4755.32
BATM Advanced Communications£104.57M0.39-£278.26K-£3.94N/A

22.2% of EKF Diagnostics shares are held by institutional investors. Comparatively, 14.3% of BATM Advanced Communications shares are held by institutional investors. 40.2% of EKF Diagnostics shares are held by company insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

EKF Diagnostics has a beta of 0.499, indicating that its stock price is 50% less volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, indicating that its stock price is 25% less volatile than the broader market.

EKF Diagnostics has a net margin of 4.86% compared to BATM Advanced Communications' net margin of -15.91%. EKF Diagnostics' return on equity of 3.58% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
EKF Diagnostics4.86% 3.58% 5.27%
BATM Advanced Communications -15.91%-25.90%0.58%

EKF Diagnostics presently has a consensus price target of GBX 35, suggesting a potential upside of 34.62%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, research analysts plainly believe EKF Diagnostics is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EKF Diagnostics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, EKF Diagnostics had 4 more articles in the media than BATM Advanced Communications. MarketBeat recorded 5 mentions for EKF Diagnostics and 1 mentions for BATM Advanced Communications. BATM Advanced Communications' average media sentiment score of 1.10 beat EKF Diagnostics' score of 0.38 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
EKF Diagnostics
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BATM Advanced Communications
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

EKF Diagnostics beats BATM Advanced Communications on 13 of the 16 factors compared between the two stocks.

How does BATM Advanced Communications compare to INSPECS Group?

BATM Advanced Communications (LON:BVC) and INSPECS Group (LON:SPEC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

14.3% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 0.2% of INSPECS Group shares are owned by institutional investors. 31.0% of BATM Advanced Communications shares are owned by insiders. Comparatively, 19.6% of INSPECS Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

BATM Advanced Communications has higher earnings, but lower revenue than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than BATM Advanced Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£104.57M0.39-£278.26K-£3.94N/A
INSPECS Group£193.23M0.52-£4.11M-£9.40N/A

BATM Advanced Communications has a beta of 0.754, indicating that its share price is 25% less volatile than the broader market. Comparatively, INSPECS Group has a beta of 1.603, indicating that its share price is 60% more volatile than the broader market.

INSPECS Group has a net margin of -0.52% compared to BATM Advanced Communications' net margin of -15.91%. INSPECS Group's return on equity of -1.19% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-15.91% -25.90% 0.58%
INSPECS Group -0.52%-1.19%0.45%

In the previous week, BATM Advanced Communications had 1 more articles in the media than INSPECS Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for INSPECS Group. BATM Advanced Communications' average media sentiment score of 1.10 beat INSPECS Group's score of -0.34 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
INSPECS Group Neutral

Summary

BATM Advanced Communications beats INSPECS Group on 8 of the 13 factors compared between the two stocks.

How does BATM Advanced Communications compare to Creo Medical Group?

Creo Medical Group (LON:CREO) and BATM Advanced Communications (LON:BVC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Creo Medical Group has a net margin of 88.33% compared to BATM Advanced Communications' net margin of -15.91%. Creo Medical Group's return on equity of 9.56% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Creo Medical Group88.33% 9.56% -20.09%
BATM Advanced Communications -15.91%-25.90%0.58%

In the previous week, BATM Advanced Communications had 1 more articles in the media than Creo Medical Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for Creo Medical Group. BATM Advanced Communications' average media sentiment score of 1.10 beat Creo Medical Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Overall Sentiment
Creo Medical Group Neutral
BATM Advanced Communications Positive

BATM Advanced Communications has higher revenue and earnings than Creo Medical Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Creo Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Creo Medical Group£6M9.72-£25.04M£1.0012.00
BATM Advanced Communications£104.57M0.39-£278.26K-£3.94N/A

44.1% of Creo Medical Group shares are owned by institutional investors. Comparatively, 14.3% of BATM Advanced Communications shares are owned by institutional investors. 7.0% of Creo Medical Group shares are owned by company insiders. Comparatively, 31.0% of BATM Advanced Communications shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Creo Medical Group has a beta of 1.563854, meaning that its stock price is 56% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, meaning that its stock price is 25% less volatile than the broader market.

Summary

Creo Medical Group beats BATM Advanced Communications on 7 of the 13 factors compared between the two stocks.

How does BATM Advanced Communications compare to Intelligent Ultrasound Group?

BATM Advanced Communications (LON:BVC) and Intelligent Ultrasound Group (LON:IUG) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

BATM Advanced Communications has a beta of 0.754, meaning that its stock price is 25% less volatile than the broader market. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

BATM Advanced Communications has higher revenue and earnings than Intelligent Ultrasound Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Intelligent Ultrasound Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£104.57M0.39-£278.26K-£3.94N/A
Intelligent Ultrasound Group£6.57M0.00-£2.27M-£0.68N/A

BATM Advanced Communications has a net margin of -15.91% compared to Intelligent Ultrasound Group's net margin of -23.11%. Intelligent Ultrasound Group's return on equity of -23.58% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-15.91% -25.90% 0.58%
Intelligent Ultrasound Group -23.11%-23.58%-13.51%

In the previous week, BATM Advanced Communications had 1 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for Intelligent Ultrasound Group. BATM Advanced Communications' average media sentiment score of 1.10 beat Intelligent Ultrasound Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
Intelligent Ultrasound Group Neutral

14.3% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are held by institutional investors. 31.0% of BATM Advanced Communications shares are held by company insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

BATM Advanced Communications beats Intelligent Ultrasound Group on 9 of the 12 factors compared between the two stocks.

How does BATM Advanced Communications compare to Novacyt?

BATM Advanced Communications (LON:BVC) and Novacyt (LON:NCYT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

BATM Advanced Communications has a beta of 0.754, meaning that its share price is 25% less volatile than the broader market. Comparatively, Novacyt has a beta of 1.112, meaning that its share price is 11% more volatile than the broader market.

14.3% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 10.7% of Novacyt shares are owned by institutional investors. 31.0% of BATM Advanced Communications shares are owned by insiders. Comparatively, 0.4% of Novacyt shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

BATM Advanced Communications has higher revenue and earnings than Novacyt. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£104.57M0.39-£278.26K-£3.94N/A
Novacyt£20.03M1.50-£36.80M-£32.00N/A

BATM Advanced Communications has a net margin of -15.91% compared to Novacyt's net margin of -103.08%. BATM Advanced Communications' return on equity of -25.90% beat Novacyt's return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-15.91% -25.90% 0.58%
Novacyt -103.08%-96.44%-27.98%

In the previous week, BATM Advanced Communications had 1 more articles in the media than Novacyt. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for Novacyt. BATM Advanced Communications' average media sentiment score of 1.10 beat Novacyt's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Overall Sentiment
BATM Advanced Communications Positive
Novacyt Neutral

Summary

BATM Advanced Communications beats Novacyt on 10 of the 13 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsHealthcare Equipment & Supplies IndustryHealthcare SectorLON Exchange
Market Cap£40.47M£5.47B£7.19B£2.87B
Dividend Yield3.52%1.79%2.57%6.26%
P/E Ratio-3.0225.15274.29366.64
Price / Sales0.3990.40683.5990,001.44
Price / Cash2.1232.7477.0127.89
Price / Book0.515.7610.476.34
Net Income-£278.26K£151.55M£3.48B£5.89B
7 Day Performance3.48%0.65%0.85%0.14%
1 Month Performance-1.56%-3.23%-0.10%0.11%
1 Year Performance-28.53%13.02%18.03%19.40%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 11.90
+3.0%
N/A-34.3%£40.47M£104.57MN/A980
EKF
EKF Diagnostics
2.6422 of 5 stars
GBX 25.16
-0.6%
GBX 35
+39.1%
-17.0%£108.18M£51.56M53.53356
SPEC
INSPECS Group
N/AGBX 96
flat
GBX 60
-37.5%
+117.2%£104.81M£191.70MN/A1,673
CREO
Creo Medical Group
N/AGBX 13
+1.0%
GBX 40
+207.7%
+0.1%£63.16M£6M13.00279
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57MN/A65

Related Companies and Tools


This page (LON:BVC) was last updated on 9/18/2026 by MarketBeat.com Staff.
From Our Partners